Table 1

Demographic and clinical characteristics of the sample (n=216)

Variablen (%)
Sex
 Male87 (40.3)
 Female129 (59.7)
Marital status
 Married199 (92.1)
 Separated/divorced/widowed17 (7.9)
Educational background
 Junior high school or below153 (70.8)
 High school35 (16.2)
 University or above28 (13.0)
Employment status
 Employed14 (6.5)
 Medical leave10 (4.6)
 Unemployed68 (31.5)
 Retired82 (38.0)
 Others42 (19.4)
Monthly family income (¥)
 <5000166 (76.9)
 ≥500050 (23.1)
MM type
 IgG type119 (55.1)
 IgA type79 (36.6)
 IgD type9 (4.2)
 Light chain type7 (3.2)
 Others2 (0.9)
Disease staging
 New diagnosis13 (6.0)
 Induction chemotherapy91 (42.1)
 Consolidation chemotherapy62 (28.7)
 Platform stage27 (12.5)
 Unclear7 (3.2)
 Recurrence16 (7.4)
Use of painkillers, antidepressants or hypnotic drugs
 No169 (78.2)
 Yes47 (21.8)
Number of complications
 05 (2.3)
 1145 (67.1%)
 244 (20.4%)
 ≥322 (10.2%)
Types of complications
 Multiple myeloma bone disease97 (44.9)
 Impairment of renal function32 (14.8)
 Anaemia71 (32.9)
 Hypercalcaemia5 (2.3)
 Thrombosis5 (2.3)
 Inflammation40 (18.5)
 Other complications53 (24.5)
Treatment
 Oral drug therapy8 (3.7)
 Chemotherapy170 (78.7)
 Autologous haematopoietic stem cell transplantation19 (8.8)
 Others19 (8.8)
BMI
 <18.514 (6.5)
 18.5–23.9136 (63.0)
 24–27.952 (24.0)
 >27.914 (6.5)
Daily step counts
 <5000154 (71.3)
 ≥500062 (28.7)
  • BMI, body mass index; MM, multiple myeloma.